Cancer mutations explored using organoids and CRISPR
Organoids and CRISPR/Cas9 have been combined in a novel method to study genetic mutations occurring in cancer...
A cancer that forms in tissues of the breast. Breast cancers occur in both women and men, although male breast cancer is rare.
Organoids and CRISPR/Cas9 have been combined in a novel method to study genetic mutations occurring in cancer...
US researchers have developed a new blood test to detect cancer-related DNA alterations before patients experience symptoms...
by Dr Lea Goetz
A study of almost 10,000 women carrying BRCA mutations has revealed the best estimate yet of their risk in developing breast and ovarian cancer...
A highly-sensitive DNA blood test could help detect cancer years before tumours are detected...
A drug treatment for ovarian cancer has shown success against inherited breast cancer...
A common chemical found in household products could increase the risk of cancer by blocking the ability of cells to fix genetic flaws which lead to the disease...
Researchers have discovered a new approach to slow the rate of breast cancer tumour growth in mice...
The US Food and Drug Administration has approved the first genetic test to estimate an individual's risk of disease that can be sold directly to consumers...
A new study has found that up to 66 percent of cancer-causing mutations can be attributed to random mistakes made during DNA replication...
A genetic study of breast cancer patients suggests that existing drugs for treating rare breast and ovarian cancers may help more patients than previously thought...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.